Biotech Catches Major Premarket Bid Following FDA Approval
03 Aprile 2024 - 4:25PM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Vanda Pharmaceuticals (NASDAQ:VNDA)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Vanda Pharmaceuticals (NASDAQ:VNDA)
Storico
Da Mag 2023 a Mag 2024